HCFP/Capital Partners 18B-1 LLC 13D and 13G filings for Scopus BioPharma Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2021-11-26 5:04 pm Purchase |
2021-11-23 | 13D | Scopus BioPharma Inc. SCPS |
HCFP/Capital Partners 18B-1 LLC | 1,587,092 7.500% |
83,758![]() (+5.57%) |
Filing |
2021-02-12 9:51 pm Purchase |
2020-12-31 | 13G | Scopus BioPharma Inc. SCPS |
HCFP/Capital Partners 18B-1 LLC | 1,503,334 10.300% |
1,503,334![]() (New Position) |
Filing |